Cite
Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial.
MLA
d’Ettorre, Gabriella, et al. “Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial.” PLoS ONE, vol. 9, no. 10, Oct. 2014, pp. 1–10. EBSCOhost, https://doi.org/10.1371/journal.pone.0109791.
APA
d’Ettorre, G., Baroncelli, S., Micci, L., Ceccarelli, G., Andreotti, M., Sharma, P., Fanello, G., Fiocca, F., Cavallari, E. N., Giustini, N., Mallano, A., Galluzzo, C. M., Vella, S., Mastroianni, C. M., Silvestri, G., Paiardini, M., & Vullo, V. (2014). Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial. PLoS ONE, 9(10), 1–10. https://doi.org/10.1371/journal.pone.0109791
Chicago
d’Ettorre, Gabriella, Silvia Baroncelli, Luca Micci, Giancarlo Ceccarelli, Mauro Andreotti, Prachi Sharma, Gianfranco Fanello, et al. 2014. “Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial.” PLoS ONE 9 (10): 1–10. doi:10.1371/journal.pone.0109791.